‘Pharma bro’ Martin Shkreli heads into fraud trial Whitecourt Press June 26, 2017 1 min read Prosecutors have accused Shkreli of lying to investors in the hedge fund and siphoning millions of dollars in assets from biopharmaceutical company Retrophin Inc to repay them
